Douglas Lane & Associates LLC Decreases Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Douglas Lane & Associates LLC reduced its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 3.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 63,274 shares of the healthcare conglomerate's stock after selling 2,516 shares during the quarter. Douglas Lane & Associates LLC's holdings in UnitedHealth Group were worth $33,312,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of UNH. Robbins Farley purchased a new position in UnitedHealth Group in the 3rd quarter valued at $25,000. Richelieu Gestion SA acquired a new stake in UnitedHealth Group in the fourth quarter valued at about $26,000. CGC Financial Services LLC raised its stake in shares of UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after buying an additional 50 shares in the last quarter. NewSquare Capital LLC boosted its stake in shares of UnitedHealth Group by 340.0% in the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate's stock valued at $33,000 after buying an additional 51 shares in the last quarter. Finally, Strategic Investment Solutions Inc. IL purchased a new position in UnitedHealth Group in the first quarter worth $35,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Down 0.8 %

UNH traded down $4.14 during trading on Monday, hitting $485.93. The company had a trading volume of 2,785,615 shares, compared to its average volume of 4,144,438. The business has a 50-day moving average of $504.98 and a 200-day moving average of $518.70. The company has a market cap of $447.99 billion, a PE ratio of 20.38, a P/E/G ratio of 1.33 and a beta of 0.54. UnitedHealth Group Incorporated has a 1-year low of $445.68 and a 1-year high of $554.70. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.79 and a quick ratio of 0.79.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share for the quarter, topping analysts' consensus estimates of $5.98 by $0.18. The business had revenue of $94.43 billion for the quarter, compared to analysts' expectations of $92.13 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The business's quarterly revenue was up 14.1% on a year-over-year basis. During the same period in the prior year, the firm earned $5.34 EPS. As a group, analysts forecast that UnitedHealth Group Incorporated will post 27.82 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were given a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.55%. UnitedHealth Group's dividend payout ratio (DPR) is 31.54%.

Analysts Set New Price Targets

UNH has been the topic of a number of research reports. Cantor Fitzgerald restated an "overweight" rating and issued a $591.00 price target on shares of UnitedHealth Group in a report on Friday, January 19th. Royal Bank of Canada reissued an "outperform" rating and issued a $596.00 price objective on shares of UnitedHealth Group in a research note on Thursday, February 29th. Truist Financial reissued a "buy" rating and set a $610.00 price objective on shares of UnitedHealth Group in a research note on Thursday, November 30th. Bank of America reiterated a "buy" rating and set a $675.00 target price on shares of UnitedHealth Group in a report on Thursday, March 7th. Finally, Stephens reaffirmed an "overweight" rating and set a $605.00 price objective on shares of UnitedHealth Group in a research note on Thursday, February 8th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $579.33.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a document filed with the SEC, which is available at this link. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the business's stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company's stock, valued at approximately $4,527,306.72. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares of the company's stock, valued at $16,977,233.31. The disclosure for this sale can be found here. Company insiders own 0.35% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.